Tepezza, also known asTeprotumumab, is an IV infusion drug prescribed to adults with thyroid eye disease (TED), a rare condition where the eyes bulge outward from inflammation in the muscles and fatty tissues behind the eye.
TED can cause a number of complications such as eye pain, double vision, light sensitivity or difficulty closing the eye that often inhibit the ability to drive or work.
Tepezza was the first-ever medication approved by the FDA for the treatment of TED, and as a result it received Fast Track, Priority Review and Breakthrough Therapy Designation by the agency. Perhaps due to this, the side effects on patients weren’t fully disclosed.
Although Horizon Pharma initially reported minimal hearing loss side effects in only 10% of users from its own clinical trials, experts now warn that Tepezza patients may have a significantly higher risk of hearing loss from the drug.
A 2021 Stanford University study revealed that a staggering 65% of patients receiving Tepezza reported hearing loss, most after just three treatments. Hearing problems included:
Due to the failure of Horizon Pharma to warn patients of the hearing loss injuries linked to Tepezza, lawyers believe the company will be liable for substantial damages to those affected. They’ve begun filing Tepezza lawsuits on behalf of anyone who suffered hearing loss of changes after taking the drug.
Latest Information on the Tepezza hearing loss litigation.
While there is no single Tepezza hearing loss class action lawsuit, lawyers are requesting that a special federal court be established that will provide greater access to justice for the potential thousands of individual victims.
In late 2022, lawyers representing a group of victims asked that Tepezza hearing loss lawsuits be consolidated into a federal multidistrict litigation (MDL) court in Northern Illinois.
This type of specialized court will be more beneficial to victims than a Tepezza Class Action Lawsuit. In a class action, one group of lawyers usually gathers class participants, who must then share whatever is awarded.
However, in an MDL court, individual victims are able to share valuable medical evidence while maintaining the ability to select their own lawyer, exercise more control over their case and whether it settles, and reap higher award amounts for their separate lawsuit.
With the potential for over 5,000 claims, lawyers expect some Tepezza lawsuits will proceed to trial in front of a jury. This could pave the way for others to avoid litigation and take part in a larger settlement program from the company.
DrugNews works only with lawyers that are integrally involved in the Tepezza litigation and have handled thousands of drug injury and hearing loss lawsuits.
If you or a loved one developed hearing problems after being administered the drug Tepezza, it’s important to have a lawyer investigate your case to see if you have the right to recover damages.
Our qualified drug injury lawyers will fully examine your case, reviewing medical records and drug safety research that your doctor may not normally discuss.
Product injury laws may allow between two to four years from the date of injury for victims and their families to file claims. However, you should begin the process as early as possible to make sure your lawyer has time to get necessary records and prepare your case.
DrugNews works only with attorneys and law firms that have successfully handled tens of thousands of lawsuits involving injury or death from harmful drugs and defective products. And, we’ll connect you directly to a lawyer or patient advocate today, so you’ll be able to decide if you want to proceed.
We make it easy to get help, find out if you qualify, and quickly file a claim. Our service is offered at no cost to you, and you won’t pay anything to your attorney unless you receive an award. Also, our qualified lawyers can handle most aspects of your case without you ever leaving your home.
For more information, or to learn about your options - call, chat or email us today.
Call, email or live chat with us today to see how we can help.